Safety and Efficacy of Three Formulations of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution

Exclusion Criteria

• •Ocular hyperemia or other ocular surface findings in either eye
• •Active ocular disease
• •Current or anticipated use of any topical ocular medication (including artificial tears) during the study
• •Intraocular surgery within past six months or unilateral cataract surgery.
• •Functionally significant visual field loss
• •Anticipated wearing of contact lenses during study
• •Use of other medications that affect IOP such as glaucoma treating medications, within 2 months of screening visit